Logo-bi
Editorial
Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(2): 65-69. doi: 10.15171/bi.2015.18
PMCID: PMC4492186     PMID: 26191499     Scopus ID: 84930410369    
PDF
XML
Cited By:
Perspective
Mohammad A. Rafi, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(3): 117-122. doi: 10.15171/bi.2015.22
PMCID: PMC4597158     PMID: 26457248     Scopus ID: 84944384880    
PDF
XML
Cited By:
Review
Farnaz Fahimi, Mohammad Reza Tohidkia, Mehdi Fouladi, Reza Aghabeygi, Naser Samadi, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(1): 59-71. doi: 10.15171/bi.2017.08
PMCID: PMC5439391     PMID: 28546954     Scopus ID: 85019068034    
Editorial
Nastran Hashemzadeh, Khosro Adibkia ORCID, Jaleh Barar* ORCID
Bioimpacts. 2019;9(1): 1-3. doi: 10.15171/bi.2019.01
PMCID: PMC6378097     PMID: 30788254     Scopus ID: 85060480524    
Original Research
Sevda Jafari ORCID, Saba Heydarian, Raymond Lai, Elnaz Mehdizadeh Aghdam, Ommoleila Molavi* ORCID
Bioimpacts. 2023;13(1): 51-61. doi: 10.34172/bi.2022.23698
PMCID: PMC9923812     PMID: 36816998     Scopus ID: 85152099837    
Evaluation of different variables on preparation of Microspheres. F9; Freeze-dried particles prepared by W/O/W emulsion method, F1; Dried particles on the tray at room temperature, F16; Freeze-dried particles prepared by S/O/O emulsion method. W/O/W; Water in oil in water, S/O/O; Solid in oil in oil.
Review
Leila Rostamizadeh ORCID, Ommoleila Molavi* ORCID, Mohsen Rashid, Fatemeh Ramazani, Behzad Baradaran, Afsaneh Lavasanaifar, Raymond Lai
BioImpacts. 2022;12(3): 261-290. doi: 10.34172/bi.2022.23896
PMCID: PMC9124882     PMID: 35677663     Scopus ID: 85132074584    
In this paper, we will review the application of the four most widely studied TLR agonists including agonists of TLR3, 4, 7, and 9 in cancer immunotherapy.
Original Article
Xiuying Li* ORCID, Xianqin Luo, Shunqin Hu
Bioimpacts. 2023;13(2): 89-96. doi: 10.34172/bi.2023.24166
PMCID: PMC10182444     PMID: 37193073     Scopus ID: 85152093865    
Our results indicated that losartan can modulate the tumor microenvironment, and improve the efficacy of anti-PD-L1 mAb.
Review
Katelyn R. Einloth ORCID, Scott Gayfield, Thomas McMaster, Alexander Didier, Lance Dworkin, Justin Fortune Creeden* ORCID
Bioimpacts. 2023;13(6): 439-455. doi: 10.34172/bi.2023.27521
PMCID: PMC10676524     PMID: 38022382    
Original Article
Seyed Mostafa Monzavi ORCID, Amir Ali Hamidieh ORCID, Mohammad Vasei, Jafar Ai, Naser Ahmadbeigi, Hamid Arshadi, Samad Muhammadnejad* ORCID, Abdol-Mohammad Kajbafzadeh* ORCID
Bioimpacts. 2023;13(5): 415-424. doi: 10.34172/bi.2023.27576
PMCID: PMC10509739     PMID: 37736339    
Original Article
Hamed Zare ORCID, Hamid Bakherad* ORCID, Arman Nasr Esfahani, Mohamad Norouzi, Hossein Aghamollaei, Seyed Latif Mousavi Gargari, Fatemeh Mahmoodi, Mahdi Aliomrani, Walead Ebrahimizadeh
Bioimpacts. 2024;14(2): 27829. doi: 10.34172/bi.2023.27829
PMCID: PMC10945302     PMID: 38505675    
PDF
XML
Cited By:
Review
Maryam Samareh Salavatipour ORCID, Zahra Poursalehi, Negin Hosseini Rouzbahani, Sohaib Mohammadyar, Mohammad Vasei* ORCID
Bioimpacts. 2024;14(6): 30087. doi: 10.34172/bi.2024.30087
PDF
XML
Cited By: